The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Blood Pressure Outcome of Angioplasty in Atherosclerotic Renal Artery Stenosis: A Randomized Trial
Open accessAbstract
Abstract —Data for the effects on blood pressure of renal artery balloon angioplasty are mostly from uncontrolled studies. The aim of this study was to document the efficacy and safety of angioplasty for lowering blood pressure in patients with atherosclerotic renal artery stenosis. Patients were randomly assigned antihypertensive drug treatment (control group, n=26) or angioplasty (n=23). Twenty-four-hour ambulatory blood pressure, the primary end point, was measured at baseline and at termination. Termination took place 6 months after randomization or earlier in patients who developed refractory hypertension. In those allocated angioplasty, antihypertensive treatment was discontinued after the procedure but was subsequently resumed if hypertension persisted. Secondary end points were the treatment score and the incidence of complications. Two patients in the control group and 6 in the angioplasty group suffered procedural complications (relative risk, 3.4; 95% confidence interval, 0.8 to 15.1). Early termination was required for refractory hypertension in 7 patients in the control group. Antihypertensive treatment was resumed in 17 patients in the angioplasty group. Mean ambulatory blood pressure at termination did not differ between control (141±15/84±11 mm Hg) and angioplasty (140±15/81±9 mm Hg) groups. Angioplasty reduced by 60% the probability of having a treatment score of 2 or more at termination (relative risk, 0.4; 95% confidence interval, 0.2 to 0.7). There was 1 case of dissection with segmental renal infarction and 3 of restenosis in the angioplasty group. No patient suffered renal artery thrombosis. In unilateral atherosclerotic renal artery stenosis, angioplasty is a drug-sparing procedure that involves some morbidity. Previous uncontrolled and unblinded assessments of angioplasty overestimated its potential for lowering blood pressure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Blum, U., Krumme, B., Flügel, P., Gabelmann, A., Lehnert, T., Buitrago-Tellez, C., Schollmeyer, P., & Langer, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702133360702 · Cited by 508
Anderson, G. H., Blakeman, N., & Streeten, D. H. P. (1994) · Journal of Hypertension · doi:10.1097/00004872-199405000-00015 · Cited by 403
Atherosclerotic Renovascular Disease and Progressive Renal Failure
Rimmer, J. M., & Gennari, F. J. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-9-199305010-00010 · Cited by 396
Effect of renal-artery stenting on progression of renovascular renal failure
Harden, P., MacLeod, M., Rodger, R., Baxter, G., Connell, J., Dominiczak, A., Junor, B., Briggs, J., & Moss, J. (1997) · The Lancet · doi:10.1016/s0140-6736(96)10093-3 · Cited by 367
Effect of Renal-Artery Stenting on Progression of Renovascular Renal Failure
Harden, P. N., MacLeod, M. J., Rodger, R. S. C., Baxter, G. M., Connell, J. M. C., Dominiczak, A. F., Junor, B. J. R., Brigs, J. D., & Moss, J. G. (1999) · The Journal of Urology · doi:10.1097/00005392-199903000-00090 · Cited by 356
Pickering, T., Devereux, R., James, G., Silane, M., Herman, L., Sotelo, J., Sos, T., & Laragh, J. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92668-2 · Cited by 301
Prevalence of primary and secondary hypertension: studies in a random population sample.
Berglund, G., Andersson, O., & Wilhelmsen, L. (1976) · BMJ · doi:10.1136/bmj.2.6035.554 · Cited by 266
Weibull, H., Bergqvist, D., Bergentz, S.-E., Jonsson, K., Hulthén, L., & Manhem, P. (1993) · Journal of Vascular Surgery · doi:10.1016/0741-5214(93)90340-r · Cited by 246
Ramsay, L. E., & WALLER, P. C. (1990) · BMJ · doi:10.1136/bmj.300.6724.569 · Cited by 238
Renal artery stenosis and hypertension
Derkx, F. H. M., & Schalekamp, M. A. D. H. (1994) · The Lancet · doi:10.1016/s0140-6736(94)93002-3 · Cited by 236
Renal artery stenosis: A common and important problem in patients with peripheral vascular disease
Missouris, C. G., Buckenham, T. M., Cappuccio, F. P., & MacGregor, G. A. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90109-0 · Cited by 223
Canzanello, V. J., Millan, V. G., Spiegel, J. E., Ponce, P. S., Kopelman, R. I., & Madias, N. E. (1989) · Hypertension · doi:10.1161/01.hyp.13.2.163 · Cited by 164
Restenosis after a first percutaneous transluminal renal angioplasty.
Plouin, P., Darné, B. M., Châtellier, G., Pannier-Moreau, I., Battaglia, C., Raynaud, A. C., & Azizi, M. (1993) · Hypertension · doi:10.1161/01.hyp.21.1.89 · Cited by 147
Self-citationComparison of dose standard units for drug utilisation studies
Merlo, J., Wessling, A., & Melander, A. (1996) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050064 · Cited by 131
Apparent Prevalence of Curable Hypertension in the Hypertension Detection and Follow-up Program
Lewin, A. J. (1985) · Archives of Internal Medicine · doi:10.1001/archinte.1985.00360030056011 · Cited by 112
Effect of Age on Response of Secondary Hypertension to Specific Treatment
Streeten, D. H. P., Anderson, G. H., & Wagner, S. (1990) · American Journal of Hypertension · doi:10.1093/ajh/3.5.360 · Cited by 76
Microvascular function in human essential hypertension
Shore, A. C., & Tooke, J. E. (1994) · Journal of Hypertension · doi:10.1097/00004872-199407000-00001 · Cited by 75
Brawn, L. A., & Ramsay, L. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91203-7 · Cited by 61
Variability of Indirect Methods Used to Determine Blood Pressure
Bottini, P. B. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.1.139 · Cited by 44
An evaluation of the A& D UA-751 semi-automated cuff-oscillometric sphygmomanometer
Jamieson, M. J., Webster, J., Witte, K., Huggins, M. M., MacDonald, T. M., de Beaux, A., & Petrie, J. C. (1990) · Journal of Hypertension · doi:10.1097/00004872-199004000-00012 · Cited by 34
Research works printed but not linked: 6
- 10.1001/jama.1992.03490230083033 · doi:10.1001/jama.1992.03490230083033
- Scottish and Newcastle Renovascular Collaborative Group. Prospective randomized trial of interventional (angioplasty) versus medical therapy in hypertensive patients with atheromatous renal artery stenosis. J Hypertens. 1994;12:1312. Abstract.
- 10.1001/archinte.1992.00400130147019 · doi:10.1001/archinte.1992.00400130147019
- Malher F Triller J Weidmann P Nachbur B. Complications in percutaneous transluminal dilatation of renal arteries. Nephron. 1986;44(suppl 1):60–63. · doi:10.1159/000184049
- 10.1093/ajh/1.4.359 · doi:10.1093/ajh/1.4.359
- 10.7326/0003-4819-123-8-199510150-00007 · doi:10.7326/0003-4819-123-8-199510150-00007
Cited by
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,824
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Hirsch, A. T., Haskal, Z. J., Hertzer, N. R., Bakal, C. W., Creager, M. A., Halperin, J. L., Hiratzka, L. F., Murphy, W. R. C., Olin, J. W., Puschett, J. B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.174526 · Cited by 3,708
Authors/Task Force Members:, Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehm236 · Cited by 2,384
Metadata
- Authors
- Plouin, P.-F., Chatellier, G., Darné, B., & Raynaud, A.
- Venue
- Hypertension
- Published
- 1998-03
- Volume
- 31
- Issue
- 3
- Pages
- 823-829
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2122238500
- Cited by
- 585
- References
- 21
- FWCI
- 19.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.